期刊文献+

儿童纵隔神经母细胞瘤临床特征分析

Characteristics of mediastinal neuroblastoma in children
暂未订购
导出
摘要 目的:探讨纵隔神经母细胞瘤临床特征。方法:收集2008年3月至2012年9月中国医科大学附属第四医院儿科收治的神经母细胞瘤110例,其中26例肿瘤位于纵隔,其他部位84例。将纵隔神经母细胞瘤的临床表现、肿瘤标志物、生物学预后因素与其他部位对比。结果:纵隔组平均年龄25.5个月,与其他部位组相近。初诊时纵膈组88.5%有症状,高于其他部位组60.7%(P<0.05);早期病例(Ⅰ、Ⅱ期)34.6%,高于其他部位组8.3%(P<0.05);血清NSE>100 ng/L者达21.4%,低于其他部位组86.1%(P<0.001)。纵隔组N-myc基因拷贝数均<10,其他部位组N-myc基因拷贝数>10者为23.1%(P<0.05)。纵隔组4年总生存率为80.0%,其中局限性肿瘤(Ⅰ、Ⅱ、Ⅲ期)达100%,分别高于其他部位组44.0%、82.0%。结论:多数纵隔神经母细胞瘤表现出临床分期早(Ⅰ、Ⅱ期)和良好的生物学预后因素,这些特征可能与纵隔神经母细胞瘤良好的预后相关。 Objective: The present study aimed to study the clinical characteristics of mediastinal neuroblastoma. Methods: From March 2008 to September 2012, the Fourth Affiliated Hospital of China Medical University admitted 110 cases of neuroblastoma, including 26 cases of mediastinal neuroblastoma and 84 cases of other neuroblastomas. The clinical manifestation, tumor markers, and biological prognostic factors of mediastinal neuroblastoma were compared with those of other neuroblastomas. Results: The average age of patients in the mediastinal neuroblastoma group was 25.5 months, which was very similar to other neuroblastomas. About 88.5% of mediastinal neuroblastomas had newly diagnosed syndrome, and the corresponding value was 60.7% in other neuroblastomas (P〈 0.05). The early-stage (Ⅰ and Ⅱ) cases in the mediastinal neuroblastoma group were 34.6%, higher than that in the other neuroblastomas, i.e., 8.3% (P〈0.05). About 21.4% of the serum NSE levels of the mediastinal neuroblastoma group increased by 〉100 ng/L, which was lower than the 86.1% (P〈0.05) in other neuroblastomas. All cases of mediastinal neuroblastoma had an N-myc copy number 〈10, whereas 23.1% of the other neuroblastomas had 〉10 copies (P〈0.05). The 4-year overall SUlvival rate was 80.0% in the mediastinal group and 44.0% in the other neuroblastomas. Among the cases involving primary tumors in localized neuroblastomas, the 4-year survival rate was 100%, which was significantly higher than the 82.0% in other neuroblastomas. Conclusion: The majority of mediastinal neuroblastoma cases found in the early clinical stage had favorable biological prognostic factors that may be associated with the prognosis of mediastinal neuroblastoma.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2013年第10期588-591,共4页 Chinese Journal of Clinical Oncology
基金 辽宁省科学技术计划项目(编号:2010225001)资助~~
关键词 神经母细胞瘤 纵隔 儿童 预后 ncuroblastoma, mcdiastinum, children, prognosis
  • 相关文献

参考文献12

  • 1All Shammari NF, Redha E, Al Haieri MHCervical NeonatalNeuroblastoma with Recurrent SVTJ] Gulf J Oncolog, 2009, 7(6):45-57.
  • 2Suita S,Tajiri T, Sera Y, et al The characteristics of mediastinalneuroblastoma[[] EurJ Pediatr Surg, 2000, 10(6):353-359.
  • 3Rubie H,Hartmann O, Giron A, et al Nonmetastatic thoracicneuroblastoma: A review of 40cases[J] Med Pediatr Oncol, 1991, 19(4):253-257.
  • 4Adams GA, Shochat SJ, Smith El, et al Thoracic neuroblastoma: Apediatric oncology group study[J] Pediatr Surg, 1993, 28⑶:372-378.
  • 5Demir HA, Yale B, Buyukpamukcu N, et al Thoracic Neurobias ticTumors in Childhood[J] Pediatr Blood Cancer, 2010, 54(7):885-889.
  • 6高解春,王耀平,主编现代小儿肿瘤学[M]l版上海:复旦大学出版社,2003:538- 558.
  • 7李忠元,赵强,王景福,曹嫣娜,李璋琳,闫杰.100例神经母细胞瘤临床预后分析[J].中国肿瘤临床,2011,38(3):155-158. 被引量:15
  • 8ZeltzerPM, Marangos PJ, Evans AE, et al Serum neuron—specificenolase in children with neuroblastoma Relationship to stage anddisease coursej] Cancer, 1986, 57(6):1230-1234.
  • 90Sung KW, Yoo KH, Koo HH, et al Neuroblastoma originatingfrom extra—abdominal sites: association with favorable clinical andbiological features [J] Korean Med Sci, 2009, 24(3):461-467.
  • 101Parikh D, Short M, Eshmawy M, et al Surgical outcome analysis ofpaediatric thoracic and cervical neuroblastoma[J] EurJ CardiothoracSurg, 2012, 41(3):630-634.

二级参考文献10

  • 1高晓宁,唐锁勤,林季.晚期儿童神经母细胞瘤的临床和预后分析[J].中国当代儿科杂志,2007,9(4):351-354. 被引量:7
  • 2Sung KW,Yoo KH,Koo HH,et al.Neuroblastoma originating from extra-abdominal sites:association with favorable clinical and biological features[J].J Korean Med Sci,2009,24(3):461-167.
  • 3Strenger V,Kerbl R,Dornbusch HJ,et al.Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients[J].Pediatr Blood Cancer,2007,48(5):504-509.
  • 4Riley RD,Heney D,Jones DR,et al.A systematic review of molecular and biological tumor markers in neuroblastoma[J].Clin Cancer Res,2004,10(1 Pt 1):4-12.
  • 5Agarwala SS,Keilholz U,Gilles E,et al.LDH correlation with survival in advanced melanoma from two large,randomised trials (Oblimersen GM301 and EORTC 18951)[J].Eur J Cancer,2009,45(10):1807-1814.
  • 6Matthay KK,Perez C,Seeger RC,et al.Successful treatment of stage ID neuroblastoma based on prospective biologic staging:a Children's Cancer Group study[J].J Clin Oncol,1998,16(4):1256 -1264.
  • 7Adkins ES,Sawin R,Gerbing RB,et al.Efficacy of complete resection for high -risk neuroblastoma:a Children's Cancer Group study[J].J Pediatr Surg,2004,39(6):931-936.
  • 8La Quaglia MP,Kushner BH,Su W,et al.The impact of gross total resection on local control and survival in high-risk neuroblastoma[J].J Pediatr Surg,2004,39(3):412-117.
  • 9Aydn GB,Kutluk MT,Yalcn B,et al.Neuroblastoma in Turkish children:experience of a single center[J].J Pediatr Hematol Oncol,2009,31(7):471-480.
  • 10魏光辉,金先庆.术前化疗在肾母细胞瘤的应用及研究进展[J].国外医学(泌尿系统分册),2001,21(2):96-96. 被引量:2

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部